Pharmaceutical Technology12h
FDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
Pharmaceutical Technology12h
Alzheimer’s total prevalent cases to reach 22.51 million in 8MM in 2033
GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimer’s disease in 2033.
Pharmaceutical Technology15h
Climb Bio enters licensing deal with Mabworks for CLYM116 development
Climb Bio has entered an exclusive licence agreement with Beijing Mabworks Biotech for developing and commercialising CLYM116.
Pharmaceutical Technology18h
A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours
A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T cell therapies for solid tumour cancers.
Pharmaceutical Technology18h
Light Horse emerges with $62m and Novartis partnership worth up to $1bn
Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.
Pharmaceutical Technology19h
Coave Therapeutics raises $33m in funding to advance ALIGATER platform
Coave has raised €32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.
Pharmaceutical Technology21h
Newron and Myung In Pharm sign agreement for evenamide development
Newron and Myung In Pharm have signed a licence agreement for evenamide, for schizophrenia treatment in South Korea.
Pharmaceutical Technology23h
Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe
Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and Mitsubishi Tanabe with deals announced on the same day.